Dialysis Catheter Market Size, Share, & Trends Analysis | Global | 2026-2032 | MedCore | Includes: Hemodialysis and Peritoneal Dialysis Catheters

Product Description

The global dialysis market was valued at $331 million in 2025. This is expected to increase over the forecast period at a CAGR of 2.6% to reach over $397 million by 2032.

The full report suite on the global market for dialysis catheters includes long-term hemodialysis catheters, short-term hemodialysis catheters and peritoneal dialysis catheters. Long-term hemodialysis catheters are typically suited for situations demanding catheter retention beyond three weeks, with dwell times stretching over months or even years. Within this segment, the market is further divided into conventional and advanced material catheters. Conversely, short-term hemodialysis catheters find application when catheter use is not anticipated to surpass three weeks or in emergency scenarios necessitating immediate catheter insertion.

Data Types Included

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2032, and Historical Data to 2022
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

Dialysis Catheter Market Trends

Dialysis catheters continue to play a critical role where permanent vascular access is not possible, but their elevated infection and complication rates limit broader adoption. Because they carry higher clinical risk than arteriovenous fistulae or grafts, catheters are typically used as temporary or last-resort access. Many dialysis patients are medically unsuitable for fistula or graft placement, so catheters remain necessary for a substantial portion of the population. Unless infection and complication rates decline meaningfully, catheter use is unlikely to increase beyond current levels relative to other access options.

Dialysis Catheter Market Share Insights

• Becton Dickinson (BD) held a strong position in the total dialysis catheter market, particularly in the long-term and short-term hemodialysis catheter segments. While the company lacked a peritoneal dialysis catheter offering, BD’s aggressive marketing strategy and volume discounts allowed it to gain market share in this competitive field. Its extensive catheter lines include both long-term and short-term options. The company dominates the market for power-injectable short-term hemodialysis catheters with devices such as Power-Trialysis® and DuoGlide®, which provide high flow rates with low recirculation and feature thermosensitive polyurethane shafts. Its long-term hemodialysis catheter portfolio is broad, including devices such as Equistream®, Duet®, HemoSplit®, HemoStar®, GlidePath®, Decathlon™ DF, Reliance XK™ and the newer Pristine™ catheter, which uses a side-hole–free Y-Tip™ design. These products incorporate advanced attributes such as SureCuff™ tissue ingrowth cuffs, antimicrobial coatings, kink-resistant shafts and AlphaCurve™ configurations to address infection risks, improve patency and enhance BD’s competitive edge in the global dialysis catheter market.
• Medtronic secured the second-leading position in the total dialysis catheter market in 2025. The company excelled in the short-term hemodialysis segment and dominated the peritoneal dialysis segment through its extensive Argyle™ peritoneal dialysis catheter line, including Tenckhoff, Curl Cath, Swan Neck, Missouri and Presternal designs. Medtronic also maintained a presence in long-term hemodialysis catheters with products such as the Mahurkar™ chronic Carbothane and silicone catheters, Permcath™ and Tandem-Cath™ dual-lumen catheters. Its Palindrome™ symmetric tip catheter, designed for minimal recirculation during line reversal, garnered strong clinical feedback and contributed to market adoption. In addition, the company offered catheters with advanced options such as antimicrobial silver sleeves and heparin coatings to address infection and thrombosis risks. However, in January 2023, Medtronic issued a Class I recall of its Mahurkar™ Acute Dual Lumen High Flow 13.5 Fr catheters due to potential catheter hub defects that could cause cross-lumen leaks and serious safety risks. Although the affected products were removed from the market, Medtronic continued to strengthen its portfolio with reliable chronic and peritoneal solutions, ensuring it remained a leading competitor in the global dialysis catheter market.
• Medcomp claimed the third-leading spot in the total dialysis catheter market in 2025, primarily excelling in the long-term dialysis catheter market and maintaining a stable presence in short-term dialysis and peritoneal dialysis catheter segments. Known for introducing split-tip catheters to the market, its products, such as Split Stream® and Split Cath®, retained a respectable market share. Medcomp adjusted prices to compete with established and emerging companies, with its Trio-CT device, a power-injectable short-term hemodialysis catheter, supporting the company’s growth in this area. Medcomp’s strategy included selling to private access facilities, such as Fresenius and DaVita, offering competitive pricing to achieve substantial sales volume.

Dialysis Catheter Market Segmentation Summary

• Dialysis Catheter Market – Further Segmented Into:
  • Device Type: Hemodialysis [Long-Term (Conventional & Advanced Material) and Short-Term (Power-Injectable & Non-Power-Injectable)] and Peritoneal Dialysis

Research Scope Summary